Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina

Journal of the American College of Cardiology

Volumn 32, Issue 5, 1998, Pages 1305-1311

  Smith, Nicholas L ^a,c   Reiber, Gayle E ^a   Psaty, Bruce M ^a   Heckbert, Susan R ^a   Siscovick, David S ^a   Ritchie, James L ^a,b   Every, Nathan R ^a,b   Koepsell, Thomas D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIHYDROPYRIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; NITRATE; PROPRANOLOL; VERAPAMIL;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; FEMALE; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ADRENERGIC BETA-ANTAGONISTS; ANGINA, UNSTABLE; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; WASHINGTON;

EID: 0032213345     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00408-2     Document Type: Article

References (42)

1. β-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982;247:1707-14.
2. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-7.
3. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. A randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-I. Lancet 1986;2:57-66.
4. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
5. Yusuf S, Sleight P, Rossi PRF, et al. Reduction in infarct size, arrhythmias, chest pain by early intravenous beta blockade in suspected acute myocardial infarction. Circulation 1983;67:I32-41.
6. Report of the Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. Early treatment of unstable angina in the coronary care unit: a randomised, double-blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Br Heart J 1986;56:400-13.
7. Yusuf S, Wittes J, Friedman L. Overview of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988;260:2259-63.
8. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:386-92.
9. Theroux P, Taeymans Y, Morisette D, et al. A randomized study comparing propanolol and diltiazem in the treatment of unstable angina. J Am Coll Cardiol 1985;5:717-22.
10. Andre-Fouet X, Usdin JP, Gayet C, et al. Comparison of short-term efficacy of diltiazem and propanolol in unstable angina at rest - a randomized trial in 70 patients. Eur Heart J 1983;4:691-8.
11. Schreiber TL, Elkhatib A, Grines CL, O'Neill. Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J Am Coll Cardiol 1995;26:577-82.
12. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarctions in the United States (1990-1993). Observations from the National Registry of Myocardial Infarctions. Circulation 1994;90:2103-14.
13. Manolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmalogical management of hypertension in the United States. Arch Intern Med 1995;155:829-37.
14. Pearle DL. Pharmacologic management of ischemic heart disease with β-blockers and calcium channel blockers. Am Heart J 1990;120:739-42.
15. Markham A, Brogden RN. Diltiazem. A review of its pharmacology and therapeutic use in older adults. Drugs Aging 1993;3:363-90.
16. Clem JR. Pharmacotherapy of ischemic heart disease. AACN Clin Issues 1995;6:404-17.
17. Prisant LM, von Dohlen T, Rogers W, et al. Pharmacotherapy of unstable angina. J Clin Pharmacol 1992;32:390-9.
18. Frishman WH. Beta-adrenergic blockers as cardioprotective agents. Am J Cardiol 1992;70:2I-6I.
19. 1 hyperselectivity of β-blocker treatment. J Cardiovasc Pharm 1995;25 (suppl 1):S35-S46.
20. Cook JR, Bigger JT, Kleiger RE, Fleiss JL, Steinman RC, Rolnitzky LM. Effect of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol 1991;17:480-84.
21. Drugs Facts and Comparisons. St. Louis: Fact and Comparisons, 1996.
22. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman and Hall, 1984.
23. Rosenbaum PR, Rubin BD. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
24. Cook EF, Goldman L. Performance of tests of significance based on stratification by a multivariate confounder score or by a propensity score. J Clin Epidemiol 1989;42:317-24.
25. Singh N, Mironov D, Goodman S, et al. Treatment of silent ischemia in unstable angina: a randomized comparison of sustained-release verapamil versus metoprolol. Clin Cardiol 1995;18:653-8.
26. Rehnqvist N, Hjemdahl P, Billing E, et al. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS). Eur Heart J 1996;17:76-81.
27. Muller JE, Turi ZG, Pearle DL, et al. Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. Circulation 1984;69:728-39.
28. Management Decision and Research Center and the Foundation for Health Services Research. Resources for research and decision making. An annotated database inventory. Med Care 1996;34:MS111-46.
29. Stone PH, Thompson B, Aderson HV, et al., for the TIMI III Registry Study Group. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction. JAMA 1996;275:1104-12.
30. Pashos CL, Normand SLT, Garfinkle JB, et al. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. J Am Coll Cardiol 1994;23:1024-30.
31. McLaughlin TF, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction. Arch Intern Med 1996;156:799-805.
32. Hash TW, Prisant LM. β-blocker use in systolic heart failure and dilated cardiomyopathy. J Clin Pharmacol 1997;37:7-19.
33. Vantrimpont P, Rouleau JL, Wun CC, et al. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. J Am Coll Cardiol 1997;29:229-36.
34. Bech J, Madsen JK, Kelbaek H, Hvid-Jacobsen K, Skagen K. Metoprolol abolishes exercise-induced left ventricular dysfunction in patients with silent ischemia. Am J Cardiol 1996;78:871-5.
35. Szabo BM, Crijns HJGM, Wiesfeld ACP, van Veldhuisen DJ, Hillege HL, Lie KI. Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: importance of β-blockade. Am Heart J 1995;130:281-6.
36. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997;30:27-34.
37. Doughty RN, Rodgers A, Sharpe N, MacMahon S. Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. Eur Heart J 1997;18:560-5.
38. Clinical Practice Guideline. Unstable Angina: Diagnosis and Management. US Department of Health and Human Services. AHCPR Publication No. 94-0602, March 1994.
39. Braunwald E, Jones RH, Mark DB, et al. Diagnosing and managing unstable angina. Circulation 1994;90:613-22.
40. Pieper JA. Evolving role of calcium channel blockers in heart failure. Pharmacotherapy 1996;16:43S-9S.
41. Vetrovec GW. Hemodynamic and electrophysiologic effects of first- and second-generation calcium antagonists. Am J Cardiol 1994;73:34A-8A.
42. Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. Circulation 1991;83:52-60.